A detailed history of 1832 Asset Management L.P. transactions in Argenx Se stock. As of the latest transaction made, 1832 Asset Management L.P. holds 149,300 shares of ARGX stock, worth $84.2 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
149,300
Holding current value
$84.2 Million
% of portfolio
0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$434.22 - $551.9 $64.8 Million - $82.4 Million
149,300 New
149,300 $81 Million
Q3 2023

Nov 13, 2023

BUY
$369.35 - $548.43 $79.3 Million - $118 Million
214,800 New
214,800 $106 Million
Q1 2023

May 12, 2023

SELL
$334.23 - $403.65 $334,230 - $403,650
-1,000 Reduced 0.45%
220,200 $82 Million
Q4 2022

Feb 14, 2023

BUY
$342.17 - $402.31 $13.8 Million - $16.3 Million
40,400 Added 22.35%
221,200 $83.8 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $62.1 Million - $71.6 Million
180,800 New
180,800 $63.8 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.